Firm characteristics and the speed of FDA approval
Year of publication: |
1997
|
---|---|
Authors: | Olson, Mary K. |
Published in: |
Journal of economics & management strategy : JEMS. - Malden, Mass. [u.a.] : Blackwell, ISSN 1058-6407, ZDB-ID 1123863-X. - Vol. 6.1997, 2, p. 377-401
|
Subject: | USA / Food and Drug Administration | Zeit | Time | Diversifikation | Diversification | Arzneimittel | Pharmaceuticals | USA | United States | Arzneimittelrecht | Pharmaceutical law | Unternehmensfinanzierung | Corporate finance | 1990-1992 |
-
Firm Characteristics and the Speed of FDA Approval
Olson, Mary K., (2018)
-
Assessing the safety and efficacy of the FDA : the case of the prescription drug user fee acts
Philipson, Tomas J., (2005)
-
Grabowski, Henry G., (2008)
- More ...
-
Olson, Mary K., (2020)
-
Pharmaceutical expenditure and regulatory policy in the NHS
Olson, Mary K., (1992)
-
Regulatory agency discretion among competing industries : inside the FDA
Olson, Mary K., (1993)
- More ...